# Dynamic Contrast Enhanced HCC SABR Liver Study

> **NCT02847767** · NA · UNKNOWN · sponsor: **British Columbia Cancer Agency** · enrollment: 20 (estimated)

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

- **PROCEDURE:** Perfusion Imaging

## Key facts

- **NCT ID:** NCT02847767
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2016-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02847767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02847767, "Dynamic Contrast Enhanced HCC SABR Liver Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02847767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*